Acute Treatment of Migraines

A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine

Study Information

Condition Migraines
Phase III

Conquest Research needs volunteers for a migraine trial evaluating a nasal medication designed to help treat patients suffering from acute migraine attacks. You may qualify if you:

  • Are between the age of 18 and 65

  • Have at least a 1-year history of migraines

  • Experience 2 to 8 migraine headache attacks of moderate to severe intensity per month

Eligible participants will receive study-related care at no cost. Compensation for time and travel may be available. No medical insurance is required for participation.

Sign Up For A Study

    What To Expect


    Conquest Research is partnering with physician practices throughout Central Florida to raise awareness and offer clinical research opportunities to those in need.

    A mature medical doctor smiling as some of his colleagues stand in the background

    Register For A Study!